Vaccine Related Patents

• 5,888,513 Recombinant PRRSV proteins, diagnostic kits and vaccines containing such recombinant PRRSV proteins
  
  
• 5,882,652 Empty canine parvovirus capsids having CPV recombinant VP2 and vaccines having such capsids
  
  
• 5,858,368 Vaccine comprising a baculovirus produced influenza hemagglutinin protein fused to a second protein
  
  
• 5,849,303 Recombinant feline Immunodeficiency virus subunit vaccines employing baculoviral-expressed envelope glycoproteins derived from isolate NCSU-1 and their use against feline immunodeficiency virus infection
  
  
• 5,843,733 Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system
  
  
• 5,840,541 Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system
  
  
• 5,833,993 Feline immunodeficiency virus vaccine
  
  
• 5,827,696 Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system
  
  
• 5,762,939 Method for producing influenza hemagglutinin multivalent vaccines using baculovirus
  
  
• 5,672,349 Process for the expression of herpes simplex virus type 1 glycoprotein I and methods of use
  
  
• 5,632,992 Process for the expression of herpes simplex virus type 1 glycoprotein E and method of use
  
  
• 5,580,773 Chimeric immunogenic gag-V3 virus-like particles of the human immunodeficiency virus (HIV)
  
  
• 5,498,413 Recombinant subunit vaccine against porcine parvovirus
  
  
• 5,443,828 Chimeric HIV-2 gag particles
  
  
• 5,290,686 Expression of influenza a M2 protein in baculovirus
  
  
• 5,186,933 Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system
  
  
• 4,971,793 Subunit canine parvovirus vaccine
  
  
• 4,870,023 Recombinant baculovirus occlusion bodies in vaccines and biological insecticides